| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
|
66 |
C |
p. IFC
|
article
|
| 2 |
Case study on the environmental monitoring for biological manufacturing using Time-lapse Shadow Image Analysis
|
Narutaki, Shoji
|
|
|
66 |
C |
p. 1-8
|
article
|
| 3 |
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies
|
Rigsby, Peter
|
|
|
66 |
C |
p. 21-29
|
article
|
| 4 |
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019
|
Bekeredjian-Ding, Isabelle
|
|
|
66 |
C |
p. 53-61
|
article
|
| 5 |
Induction of osteogenic differentiation by demineralized and decellularized bovine extracellular matrix derived hydrogels associated with barium titanate
|
Luciana Aurora Soares do Amaral, Danielle
|
|
|
66 |
C |
p. 9-16
|
article
|
| 6 |
Potency evaluation of rabies vaccine for human use: The impact of reducing the number of animals per dilution – Part 2
|
Machado, Nathalia S.
|
|
|
66 |
C |
p. 30-34
|
article
|
| 7 |
Removal of the innocuity test from The International Pharmacopoeia and WHO recommendations for vaccines and biological products
|
Lei, Dianliang
|
|
|
66 |
C |
p. 17-20
|
article
|
| 8 |
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
|
Baay, Marc
|
|
|
66 |
C |
p. 35-40
|
article
|
| 9 |
Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report
|
Pollard, Andrew J.
|
|
|
66 |
C |
p. 41-52
|
article
|
Journal description